文献速递肝病

肝衰竭、肝性脑病与感染增加全球肝硬化队列的死亡风险

Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-07-05

研究基于全球115个中心7239例非择期入院肝硬化患者,确定与住院死亡相关的胆红素、INR、肌酐、MELD及MELD 3.0阈值,并发现肝性脑病和感染对死亡贡献最大;外部验证纳入1634例梅奥诊所移植评估队列患者,呈现相似模式。

要点

  • 与住院死亡相关的阈值为胆红素>7.5 mg/dL、INR>1.5、肌酐>1.5 mg/dL、MELD>27、MELD 3.0>28。
  • 决策树分析中肝性脑病对死亡相对贡献42.2%、感染22.2%、INR 18.6%、胆红素12.7%、肌酐4.3%。
  • 仅用肝脏特异变量时,胆红素≤7.5且INR≤1.5且无肝性脑病者死亡率3.3%,胆红素>7.5且INR>1.5且有肝性脑病者死亡率33%。

核心结论

  • 与死亡相关的入院阈值为胆红素>7.5 mg/dL、INR>1.5、肌酐>1.5 mg/dL、MELD>27和MELD 3.0>28。
  • 肝衰竭可能通过血清胆红素>7.5 mg/dL和INR>1.5来识别,肝性脑病和入院感染是死亡的促进因素。

研究设计与样本

  • 推导队列纳入全球CLEARED联盟115个中心、6大洲的7239例非择期入院肝硬化患者,随访至死亡或出院。
  • 采用入院变量、MELD 3.0、原始MELD和肝性脑病建立决策规则,以最大化阴性预测值的阈值分类住院死亡,并用决策树模型排序各预测因素的相对贡献。
  • 外部验证使用梅奥诊所3个院区的数据,共1634例梅奥移植评估队列患者。

主要发现

  • 7239例患者中808例(11.2%)院内死亡。
  • 最大化住院无移植死亡阴性预测值的阈值为胆红素≤7.5 mg/dL、肌酐≤1.5 mg/dL、INR≤1.5、MELD≤27和MELD 3.0≤28。
  • 决策树分析中各因素对死亡的相对贡献为肝性脑病42.2%、感染22.2%、INR 18.6%、胆红素12.7%、肌酐4.3%。
  • 仅用肝脏特异变量时,胆红素≤7.5且INR≤1.5且无肝性脑病患者死亡率仅3.3%,而胆红素>7.5且INR>1.5且有肝性脑病患者死亡率为33%。
  • 梅奥移植评估队列1634例患者的外部验证显示住院死亡预测模式相似。

关键数值与推荐

  • 与死亡相关的入院阈值为胆红素>7.5 mg/dL、INR>1.5、肌酐>1.5 mg/dL、MELD>27和MELD 3.0>28。
  • 最大化阴性预测值的阈值为胆红素≤7.5 mg/dL、肌酐≤1.5 mg/dL、INR≤1.5、MELD≤27和MELD 3.0≤28。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Validated cutoffs for liver failure with cirrhosis are required to define acute-on-chronic liver failure. We sought to determine the cutoff for serum bilirubin and international normalized ratio (INR), and influence of complications on inpatient mortality with the goal of defining liver failure and inpatient mortality prediction. METHODS: The derivation cohort for variables associated with mortality included 7239 patients with cirrhosis admitted nonelectively worldwide (CLEARED consortium) and followed until death/discharge. Admission variables, MELD 3.0, original MELD, and hepatic encephalopathy (HE) were used to create a decision rule to classify inpatient death using cutoffs to maximize negative predictive value and decision-tree models sorted each predictor's relative contribution. For external validation, data from 3 Mayo Clinic sites were used. RESULTS: A total of 7239 patients were included from 115 centers across 6 continents among whom 808 (11.2%) died in-hospital. Cutoffs maximizing negative predictive value for in-hospital transplant-free mortality were bilirubin ≤7.5 mg/dL, creatinine ≤1.5 mg/dL, INR ≤1.5, MELD ≤27, and MELD 3.0 ≤28. On decision tree analysis, the relative contributions to mortality were HE (42.2%), infection (22.2%), INR (18.6%), bilirubin (12.7), and creatinine (4.3%). Using only liver-specific variables, patients with bilirubin ≤7.5, INR ≤1.5, and without HE had only 3.3% mortality, whereas patients with bilirubin >7.5, INR >1.5, and HE had 33% mortality. External validation in 1634 patients from Mayo transplant evaluation cohort showed similar patterns for inpatient mortality prediction. CONCLUSIONS: Cutoffs associated with mortality are admission bilirubin >7.5 mg/dL, INR >1.5, creatinine >1.5 mg/dL, MELD >27, and MELD 3.0 >28. Liver failure may therefore be identified by the serum bilirubin >7.5 mg/dL and INR >1.5, with HE and admission infections as contributors toward mortality.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Bajaj JS, Silvey S, Mullan A, et al. Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort. Clin Gastroenterol Hepatol. 2025. PMID: 40618943. doi:10.1016/j.cgh.2025.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。